EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use

Sheng Zhao, Houhui Jiang, Yuxin Yan, Rui Wu

Clinical Rheumatology · 2026

DOI: 10.1007/s10067-026-08357-8 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Sheng Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, D…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Hydroxychloroquine. Die Arbeit nennt 18 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAntirheumatic AgentsArthritis, RheumatoidHydroxychloroquineInfectionsAdultAgedFemaleHumansMaleMiddle AgedMethotrexateProportional Hazards ModelsRespiratory Tract InfectionsRetrospective StudiesRisk FactorsUrinary Tract InfectionsChina

Stichwörter der Autor:innen

Cox regressionHydroxychloroquineInfection riskPropensity scoreRheumatoid arthritisTocilizumab

Substanzen

Antibodies, Monoclonal, HumanizedAntirheumatic AgentsHydroxychloroquineMethotrexatetocilizumab

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, Jiangxi, 330006, China.
  • Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, Jiangxi, 330006, China. ndyfy00400@ncu.edu.c…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, S., Jiang, H., Yan, Y., & Wu, R. (2026). Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08357-8

Vancouver

Zhao S, Jiang H, Yan Y, Wu R. Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-08357-8

BibTeX
@article{Zhao2026,
  author = {Zhao, Sheng and Jiang, Houhui and Yan, Yuxin and Wu, Rui},
  title = {Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use},
  journal = {Clinical Rheumatology},
  year = {2026},
  doi = {10.1007/s10067-026-08357-8}
}
Kostenlos starten →